Congress demands info from period tracking apps and data brokers, including policies on geofencing, as part of an investigation into reproductive health data
Context & Ripple Effects
The investigation lands a month after Roe's overturn turned routine health data into potential criminal evidence, when privacy advocates warned that period tracking apps share monthly timings, contraception use, and symptoms with partners or affiliates that may become evidence of a crime. The concern has a longer record: Privacy International found years earlier that popular period apps like MIA Fem and Maya were piping that same data to Facebook via their SDKs.
Congress is now asking the named apps and data brokers directly for their geofencing policies — the mechanism behind location products like SafeGraph's foot-traffic datasets, which the company pulled for Planned Parenthood visits in a voluntary retreat weeks before this inquiry opened.
First-order effects
- Period tracking app makers and data brokers must now produce their geofencing policies and data-sharing practices to Congress on the record, converting what was advocacy pressure into formal oversight.
- Brokers selling clinic-visit location data face a second front: Tapestri disclosed two companies sought device data revealing abortion clinic visits after the draft ruling leaked per its own disclosure to the Wall Street Journal.
Second-order effects
- Enforcement is already following the inquiry — the FTC sued Kochava for selling data revealing reproductive health clinic, worship, and shelter visits weeks later, signaling that brokers who don't self-curb like SafeGraph will face regulators instead.
- App developers face a forced choice between cutting third-party SDKs and ad partnerships (the Facebook pipeline Privacy International exposed) or defending those flows under congressional and legal scrutiny.
Third-order effects
- If the pattern holds, reproductive health data becomes a regulated category rather than an advertising byproduct — with location brokers' clinic-visit products either voluntarily withdrawn industry-wide or priced against litigation risk.
- Health-adjacent consumer apps may restructure around local-first storage and minimal sharing as a compliance posture, since any outbound data flow is now auditable evidence in a post-Roe legal environment.
The trend: Reproductive health data is moving from an unregulated ad-tech commodity to a formally investigated and enforcement-targeted category, with Congress and the FTC converging on the same broker ecosystem.